12/29/2017 | CV | Market Commentary: Outlook 2018: Convertibles issuance expected to increase, but views on macro factors mixed
|
12/22/2017 | CV | Market Commentary: Cobalt trading frenzy goes on; Array jumps up; WWE smacked down; EZCorp strengthens
|
12/22/2017 | CV | Market Commentary: Morning Commentary: Cobalt trading frenzy goes on; EZCorp expansion continues
|
12/21/2017 | CV | Market Commentary: Focus shifts to new year; Cobalt dominates; Medicines gains; Seacor holders don’t wait on put
|
12/21/2017 | CV | Market Commentary: Morning Commentary: Focus shifts to new year; Cobalt up again; Seacor holders don’t wait on put
|
12/20/2017 | CV | Market Commentary: Egalet exchanges convertibles; Micron surges on results; Cobalt trades ‘a little crazy’
|
12/20/2017 | CV | Market Commentary: Morning Commentary: Egalet exchanges; Micron surges on earnings; tax changes for Christmas
|
12/19/2017 | CV | Market Commentary: Converts and the tax plan; Navistar in focus; AMD, N.Y. Times-linked mandatories gain
|
12/19/2017 | CV | Market Commentary: Morning commentary: Convert sector hopes to benefit from tax plan, Navistar in focus
|
12/18/2017 | CV | Market Commentary: Bristow climbs further, Vipshop gains, Akamai above par but sources doubt staying power
|
12/18/2017 | CV | Market Commentary: Morning Commentary: Markets quiet, Akamai trades above par, but shouldn’t for long, sources say
|
12/15/2017 | CV | Market Commentary: Teva in focus, Bristow still going strong, adios to Intel
|
12/15/2017 | CV | Market Commentary: Morning Commentary: Bristow still going strong, Intel silent on conversion day
|
12/14/2017 | CV | Market Commentary: Bristow gains then eases a little, Teva better on restructuring; Cobalt bankruptcy no surprise
|
12/14/2017 | CV | Market Commentary: Morning Commentary: Bristow makes gains on market debut, Teva active
|
12/13/2017 | CV | Market Commentary: Convertibles market awaits Bristow notes; Trinity and Finisar rise; Oasis tumbles
|
12/13/2017 | CV | Market Commentary: Morning Commentary: Market waits on Bristow and Fed, Trinity and Finisar make early gains
|
12/12/2017 | CV | Market Commentary: Bristow talks new deal, Cowen’s new notes trade up on market debut, General Cable makes gains
|
12/12/2017 | CV | Market Commentary: Morning Commentary: Cowen’s new notes trade up on market debut
|
12/11/2017 | CV | Market Commentary: Cowen to price new deal; Meritor in focus; last call for Intel; market waits on Federal Reserve
|
12/11/2017 | CV | Market Commentary: Morning Commentary: Market waits on Federal Reserve, last call for Intel
|
12/8/2017 | CV | Market Commentary: New York Times-based mandatories gain; Veeco ‘beat up’; Cleveland-Cliffs, General Cable strong
|
12/8/2017 | CV | Market Commentary: Morning Commentary: New York Times-based mandatories price; Cleveland-Cliffs, General Cable strong
|
12/7/2017 | CV | Market Commentary: New trust to price mandatories, Granite Point goes wide, Cleveland-Cliff active around par
|
12/7/2017 | CV | Market Commentary: Morning Commentary: Granite Point prices wide, Cleveland-Cliff active around par
|
12/6/2017 | CV | Market Commentary: Granite Point talks new deal; Cleveland-Cliffs tops par; pharmaceutical names eyed
|
12/6/2017 | CV | Market Commentary: Morning Commentary: New paper from Cleveland-Cliffs hits the market, firms in trading
|
12/5/2017 | CV | Market Commentary: Market awaits Cleveland Cliffs issue, Depomed on the rise, General Cable in demand
|
12/5/2017 | CV | Market Commentary: Morning Commentary: Market awaits Cleveland Cliffs issue, General Cable off to the races
|
12/4/2017 | CV | Market Commentary: Cleveland Cliffs talks new deal, General Cable soars on merger news
|
12/4/2017 | CV | Market Commentary: Morning Commentary: Lam Research continues to fall, Carvana places convertible preferreds
|
12/1/2017 | CV | Market Commentary: China Lodging, beleaguered GNC regain some ground, chipmakers in focus
|
12/1/2017 | CV | Market Commentary: Morning Commentary: Beleaguered GNC, China Lodging regain some ground in early trades
|
11/30/2017 | CV | Market Commentary: Convertibles quiet as tax bill, inflation take focus, Lam Research dives, Workday, Square trade
|
11/30/2017 | CV | Market Commentary: Morning Commentary: Tax bill, inflation, Workday, Lam Research and Square
|
11/29/2017 | CV | Market Commentary: Lam Research tanks, chipmakers falter on semiconductor report; Workday weakens
|
11/29/2017 | CV | Market Commentary: Morning Commentary: Workday drops after equity high
|
11/28/2017 | CV | Market Commentary: Macro on the market’s mind, Old Republic dominates, China Lodging below par before earnings
|
11/28/2017 | CV | Market Commentary: Morning Commentary: Quiet morning as top pick for Federal Reserve goes before Senate
|
11/27/2017 | CV | Market Commentary: Square tumbles after record high, health care companies active in post-holiday lull
|
11/27/2017 | CV | Market Commentary: Morning Commentary: Palo Alto Networks continues to ride good news, Servicenow active
|
11/22/2017 | CV | Market Commentary: High trade volume for Intel continues; Everbridge, Square, Array make gains
|
11/22/2017 | CV | Market Commentary: Morning Commentary: Market quiet pre-holiday, Cypress notes resurface
|
11/21/2017 | CV | Market Commentary: Palo Alto jumps on earnings report, Array BioPharma’s new notes gain steam, Tesla active
|
11/21/2017 | CV | Market Commentary: Morning Commentary: Tesla active, Workday makes early gains
|
11/20/2017 | CV | Market Commentary: Intel continues to dominate trading, Array BioPharma upsizes exchange agreement
|
11/20/2017 | CV | Market Commentary: Morning Commentary: Intel drops in value as market again responds to call news
|
11/17/2017 | CV | Market Commentary: Intel call news shakes the market, Scorpio Tankers, Ares Capital see heavy trading volume
|
11/17/2017 | CV | Market Commentary: Morning Commentary: Intel call news hits the market, dominates trading activity
|
11/16/2017 | CV | Market Commentary: Everbridge expands on debut, RH dominates trading, Quotient eclipses Rambus, Insulet active
|
11/16/2017 | CV | Market Commentary: Morning Commentary: Everbridge expands 3 points, Rambus up, Quotient hovers around par
|
11/15/2017 | CV | Market Commentary: Rambus eclipses Quotient in trades; Everbridge to price; Emergent dips; Acorda tanks
|
11/15/2017 | CV | Market Commentary: Morning Commentary: Rambus, Quotient deals hit market, Everbridge in pipeline
|
11/14/2017 | CV | Market Commentary: Everbridge to price new deal, market awaits Rambus, Quotient; tech sector dominates trading
|
11/14/2017 | CV | Market Commentary: Morning Commentary: Rambus, Quotient deals in pipeline, Insulet drops below par, Tesla gains
|
11/13/2017 | CV | Market Commentary: Rambus, Quotient announce new deals, Square Inc. jumps, recent issues in demand
|
11/13/2017 | CV | Market Commentary: Morning Commentary: Square Inc. dominates early trades, Micron continues upwards climb
|
11/10/2017 | CV | Market Commentary: Convertibles secondary market stable despite new issues, increased credit spreads
|
11/10/2017 | CV | Market Commentary: Morning Commentary: Sarepta trades actively again with convertibles, shares higher; chip names eyed
|
11/9/2017 | CV | Market Commentary: New deals from Sarepta, Insulet trade high on reputation, new issuance drought
|
11/9/2017 | CV | Market Commentary: Morning Commentary: Sarepta’s upsized 1.5% notes ‘well received’ in market debut
|
11/8/2017 | CV | Market Commentary: Insulet, Arbor Realty deals hit market; Sarepta upsizes deal; GNC and Aegean Marine plummet
|
11/8/2017 | CV | Market Commentary: Morning Commentary: New Insulet 1.375% convertibles trade above par, high demand
|
11/7/2017 | CV | Market Commentary: Apollo add-on active in trading, Insulet deal upsized, Sarepta Therapeutics plans new deal
|
11/7/2017 | CV | Market Commentary: Morning Commentary: Apollo Commercial details add-on pricing; secondary trading active
|
11/6/2017 | CV | Market Commentary: Apollo, Insulet to price new deals, NXP Semiconductors makes gains
|
11/6/2017 | CV | Market Commentary: Morning Commentary: NXP Semiconductors, Molina convertibles trade higher
|
11/3/2017 | CV | Market Commentary: Convertibles mixed; Intel pulls back but up for week; AMAG finds footing after tumble
|
11/3/2017 | CV | Market Commentary: Morning Commentary: Convertibles mixed; AMAG finds footing after tumble following lowered guidance
|
11/2/2017 | CV | Market Commentary: New Cypress deal gains 2 points on swap; Tesla bonds lower outright, improve on swap
|
11/2/2017 | CV | Market Commentary: Morning Commentary: Iconix gains in active trade; Cypress prices new 2% convertible at the mids
|
11/1/2017 | CV | Market Commentary: New Chart Industries edges over par; older Chart trades at 101; Iconix recovers after losses
|
11/1/2017 | CV | Market Commentary: Morning Commentary: Older Chart Industries trades at 101; new Chart prices; Cypress on tap
|
10/31/2017 | CV | Market Commentary: Weibo, China Lodging trade actively; Chart deal eyed; outrights sell Intel into strength
|
10/31/2017 | CV | Market Commentary: Morning Commentary: Pricing of Chart Industries deal on tap looks ‘OK’
|
10/30/2017 | CV | Market Commentary: Ensco, Whiting Petroleum outperform; CalAtlantic issues trade on merger news; Chart on tap
|
10/30/2017 | CV | Market Commentary: Morning Commentary: Intel’s convertibles edge up; China Lodging sees follow-on trading
|
10/27/2017 | CV | Market Commentary: China Lodging convertibles move up strongly in debut trading; Intel sees heavy volume
|
10/27/2017 | CV | Market Commentary: Morning Commentary: New China Lodging convertibles move up strongly in debut trading
|
10/26/2017 | CV | Market Commentary: Weibo jumps; China Lodging on tap; Depomed eyed as Trump takes aim at ‘opioid crisis’
|
10/25/2017 | CV | Market Commentary: Cobalt sister convertibles bounce off lows; Nabors down; Shutterfly adds; Weibo deal on deck
|
10/25/2017 | CV | Market Commentary: Morning Commentary: Cobalt International Energy convertibles in mid-teens, off lows as shares sag
|
10/24/2017 | CV | Market Commentary: Ionis down in active trade; Nabors off; Illumina in line as investors eye earnings
|
10/24/2017 | CV | Market Commentary: Morning Commentary: Ionis down in active trade as shares drop; Nabors Industries weakens
|
10/23/2017 | CV | Market Commentary: Walter Investment trades at new low on reorganization news; primary market remains quiet
|
10/23/2017 | CV | Market Commentary: Morning Commentary: Walter Investment Management convertibles slump on reorganization plan
|
10/20/2017 | CV | Market Commentary: Convertibles primary quiet for third straight week; Ctrip.com trades again; Impax flat
|
10/20/2017 | CV | Market Commentary: Morning Commentary: Convertibles muted as stocks edge higher; Ctrip.com active on lower shares
|
10/19/2017 | CV | Market Commentary: Ctrip.com convertibles improve on hedged basis as stock is hit; Impax tracking toward par
|
10/19/2017 | CV | Market Commentary: Morning Commentary: Impax extends gains, trading at 97.375; Immune Pharma prices units
|
10/18/2017 | CV | Market Commentary: Convertibles trade mildly as stocks rally; Impax extends gains; DISH adds with shares
|
10/18/2017 | CV | Market Commentary: Morning Commentary: Convertibles trade mildly as stocks rally; DISH Network adds with shares
|
10/17/2017 | CV | Market Commentary: Impax Laboratories jumps in active trade after merger news; Herbalife slips; Cemex up
|
10/17/2017 | CV | Market Commentary: Morning Commentary: Impax Laboratories jumps after merger news, despite lower shares
|
10/16/2017 | CV | Market Commentary: Convertible bond players shuffle paper as stock rise continues; primary remains quiet
|
10/16/2017 | CV | Market Commentary: Morning Commentary: Isis Pharmaceuticals notches another outright gain
|
10/13/2017 | CV | Market Commentary: Caesars Entertainment, HubSpot convertibles weaken in trading; Ensco notes active
|
10/13/2017 | CV | Market Commentary: Morning Commentary: Caesars Entertainment convertibles gain over morning; Ensco notes active
|
10/12/2017 | CV | Market Commentary: Caesars Entertainment, Intel convertibles active in trading; ImmunoGen bonds, stock soften
|
10/12/2017 | CV | Market Commentary: Morning Commentary: Caesars, Intel convertible bonds remain active, softer in early trading
|
10/11/2017 | CV | Market Commentary: Convertibles mixed; Pretium up; Intel, Caesars Entertainment active in secondary market
|
10/11/2017 | CV | Market Commentary: Morning Commentary: Convertibles mixed; Intel active in secondary market, bonds soften
|
10/10/2017 | CV | Market Commentary: Convertibles mixed; Intel active, ‘trading up a storm’; Invacare, Wayfair bonds soften
|
10/10/2017 | CV | Market Commentary: Morning Commentary: Convertibles mostly quiet; HubSpot dips; Ares notes, shares improve
|
10/6/2017 | CV | Market Commentary: Convertibles market quiet as shares slip from record highs on jobs data; Intercept active
|
10/6/2017 | CV | Market Commentary: Morning Commentary: Convertible primary, secondary quiet; Intercept active as shares drop again
|
10/5/2017 | CV | Market Commentary: Convertibles buyers step in to select names; supply remains tight; Navistar 4.5s gain
|
10/5/2017 | CV | Market Commentary: Morning Commentary: Navistar 4.5% convertibles gain in active trade; market eyes data
|
10/4/2017 | CV | Market Commentary: Convertibles primary market quiet again; Tesla convertibles expand in active trade; Teva lower
|
10/4/2017 | CV | Market Commentary: Morning Commentary: Tesla convertibles higher in active trade
|
10/3/2017 | CV | Market Commentary: Convertibles subdued as pipeline shuttered; IAC/InterActiveCorp. trades up; Tesla higher
|
10/3/2017 | CV | Market Commentary: Morning Commentary: Aegean Marine convertibles get a turn; IAC/InterActiveCorp. trades up
|
10/2/2017 | CV | Market Commentary: Convertibles primary takes a pause; Trinity Industries pops on court ruling; CalAmp firms
|
10/2/2017 | CV | Market Commentary: Morning Commentary: Primary takes a pause; Trinity Industries pops on court ruling; CalAmp firms
|
9/29/2017 | CV | Market Commentary: Convertibles trade quietly in muted month-end trade; Micron extends outright gains
|
9/29/2017 | CV | Market Commentary: Morning Commentary: Convertibles moving in-line in quiet trade; month-end activity muted
|
9/28/2017 | CV | Market Commentary: Western Asset prices cheap; DexCom steals the show as convertibles drop; PTC in focus
|
9/28/2017 | CV | Market Commentary: Morning Commentary: Western Asset prices cheap; DexCom steals the show as convertibles drop
|
9/27/2017 | CV | Market Commentary: IAC’s 0.875% exchangeable notes dominate trading, top par; Western Asset joins calendar
|
9/27/2017 | CV | Market Commentary: Morning Commentary: IAC’s new 0.875% exchangeable notes dominate trading, move above par
|
9/26/2017 | CV | Market Commentary: Air Transport’s new convertibles break above par; IAC/InterActive on deck; Red Hat firm
|
9/26/2017 | CV | Market Commentary: Morning Commentary: Air Transport’s new convertibles break above par; IAC deal on deck
|
9/25/2017 | CV | Market Commentary: Air Transport, IAC/InterActive deals on tap; Marriott Vacations trades actively, better
|
9/25/2017 | CV | Market Commentary: Morning Commentary: Air Transport plans sale of seven-year convertibles; Aerojet descending
|
9/22/2017 | CV | Market Commentary: Intercept Pharmaceuticals gaps down; Merrimack, Wayfair lower; new issuance light during week
|
9/22/2017 | CV | Market Commentary: Morning Commentary: Marriott Vacations remains in focus; Intercept slide continues
|
9/21/2017 | CV | Market Commentary: Marriott Vacations adds on swap; Intercept drops about 9 points outright after FDA warning
|
9/21/2017 | CV | Market Commentary: Morning Commentary: New Marriott Vacations moves up to almost 103 in first-day trading
|
9/20/2017 | CV | Market Commentary: Meritor prices, trades up; older issues also rise; Marriott Vacations, Maxwell on tap
|
9/20/2017 | CV | Market Commentary: Morning Commentary: Meritor’s new $300 million convertibles price, trade up; older issues also rise
|
9/19/2017 | CV | Market Commentary: Sibanye brings new issue; Marriott Vacations, Maxwell add to calendar; Meritor on tap
|
9/19/2017 | CV | Market Commentary: Morning Commentary: Sibanye Gold bringing new issue; Meritor in the works; Teva trades again
|
9/18/2017 | CV | Market Commentary: Older Meritors quiet on news of new $300 million deal; newer iStar notes edge upward
|
9/18/2017 | CV | Market Commentary: Morning Commentary: Older Meritors quiet on news of new $300 million deal; Nabors edges higher
|
9/15/2017 | CV | Market Commentary: iStar’s new convertible issue breaks, gyrates around par; Wayfair, Workday active, soften
|
9/15/2017 | CV | Market Commentary: Morning Commentary: iStar’s new convertible issue breaks, trades above par in active dealings
|
9/14/2017 | CV | Market Commentary: iStar adds convertible bond offering to calendar; Wayfair, Workday trade actively
|
9/14/2017 | CV | Market Commentary: Morning Commentary: iStar adds convertible bond offering to calendar; Wayfair trades actively
|
9/13/2017 | CV | Market Commentary: Workday prices in the middle of talk, trades above par; Wayfair’s issue adds to gains
|
9/13/2017 | CV | Market Commentary: Morning Commentary: Workday prices in middle of talk; Wayfair’s new issue continues to gain
|
9/12/2017 | CV | Market Commentary: Wayfair’s new 0.375% convertibles trade up in heavy volume; Workday on tap; Teva firm
|
9/12/2017 | CV | Market Commentary: Morning Commentary: Wayfair’s new 0.375% convertibles trade up in heavy volume; Workday on tap
|
9/11/2017 | CV | Market Commentary: Wayfair, Workday add convertibles to calendar; Teva improves as new CEO named; Tesla up
|
9/11/2017 | CV | Market Commentary: Morning Commentary: Wayfair adds to calendar; Teva improves as new CEO named
|
9/8/2017 | CV | Market Commentary: Navistar edges higher after positive results; Finisar’s weak guidance worries investors
|
9/8/2017 | CV | Market Commentary: Morning Commentary: Navistar’s convertible bonds edge higher after positive quarterly results
|
9/7/2017 | CV | Market Commentary: NextEra Energy brings new deal; Electronics for Imaging gives back gains; RH improves
|
9/7/2017 | CV | Market Commentary: Morning Commentary: NextEra Energy brings new deal; Electronics for Imaging gives back gains
|
9/6/2017 | CV | Market Commentary: NextEra to price $300 million of notes; Electronics for Imaging adds as shares surge
|
9/6/2017 | CV | Market Commentary: Morning Commentary: Electronics for Imaging bonds higher as shares surge; Tesla series As active
|
9/5/2017 | CV | Market Commentary: Convertible debt investors eye recent deals from II-VI, Jazz; hurricanes pressure insurers
|
9/5/2017 | CV | Market Commentary: Morning Commentary: Convertible debt investors eye recent deals from II-VI, Jazz Pharmaceuticals
|
9/1/2017 | CV | Market Commentary: Convertibles quiet ahead of long weekend; Palo Alto Networks up in line; Acorda off lows
|
9/1/2017 | CV | Market Commentary: Morning Commentary: Palo Alto Networks moves up; Acorda Therapeutics recoups a couple of points
|
8/31/2017 | CV | Market Commentary: Impax Laboratories edges up as shares surge; Ctrip.com lower outright, mixed dollar neutral
|
8/31/2017 | CV | Market Commentary: Morning Commentary: Ctrip.com stumbles outright after quarterly results; Ciena lower with shares
|
8/30/2017 | CV | Market Commentary: Convertibles mostly name driven; Ctrip.com trades up with shares; Medicines moves around
|
8/30/2017 | CV | Market Commentary: Morning Commentary: Convertibles mostly name driven; Medicines trading action in focus
|
8/29/2017 | CV | Market Commentary: Acorda convertibles, stock beaten down as FDA sends ‘refusal to file’; Citrix improves
|
8/29/2017 | CV | Market Commentary: Morning Commentary: Acorda convertibles, stock take beating as FDA sends a ‘refusal to file’
|
8/28/2017 | CV | Market Commentary: Convertible bonds flat as trading thins in final week of August; Altaba follows stock down
|
8/28/2017 | CV | Market Commentary: Morning Commentary: Convertible bonds little changed as trading thins in final week of August
|
8/25/2017 | CV | Market Commentary: II-VI’s new 0.25% five-year notes active, give in a little; Jazz softer; Tesla falters
|
8/25/2017 | CV | Market Commentary: Morning Commentary: II-VI’s new 0.25% five-year notes remain active but give in a little
|
8/24/2017 | CV | Market Commentary: Convertibles move sideways in quiet trade; new II-VI surges in first-day trading
|
8/24/2017 | CV | Market Commentary: Morning Commentary: New II-VI 0.25% convertible notes surge 4 points in first-day trading
|
8/23/2017 | CV | Market Commentary: Prospect Capital slips ahead of earnings; II-VI deal on deck; Innoviva’s recent 2.5% notes firm
|
8/23/2017 | CV | Market Commentary: Morning Commentary: Prospect Capital slips ahead of earnings; Innoviva’s recent 2.5% notes firm
|
8/22/2017 | CV | Market Commentary: II-VI plans new Rule 144A deal; Jazz edges above issue price; Red Hat busy; Teva assets eyed
|
8/22/2017 | CV | Market Commentary: Morning Commentary: Jazz’s recent deal pushes above issue price; Red Hat, Palo Alto active
|
8/21/2017 | CV | Market Commentary: Convertibles activity wanes; Herbalife gains on news; Vipshop dips; Illumina tracks stock
|
8/21/2017 | CV | Market Commentary: Morning Commentary: Convertible market activity wanes; Herbalife little moved on news; Vipshop dips
|
8/18/2017 | CV | Market Commentary: Jazz prices at discount, fades post-pricing; AMAG convertibles hold steady; DyCom sees action
|
8/18/2017 | CV | Market Commentary: Morning Commentary: Jazz prices at discount, fades post-pricing; AMAG convertibles hold steady
|
8/17/2017 | CV | Market Commentary: GAIN comes in line; Hannon trades near par post-pricing; Jazz plans deal; Altbaba notes firm
|
8/17/2017 | CV | Market Commentary: Morning Commentary: Hannon Armstrong deal trades above par post-pricing; GAIN comes in line
|
8/16/2017 | CV | Market Commentary: Hannon Armstrong prices; GAIN deal on tap; Apollo Commercial details new 4.75% issue
|
8/16/2017 | CV | Market Commentary: Morning Commentary: Hannon Armstrong deal on tap; Apollo Commercial details new 4.75% issue
|
8/15/2017 | CV | Market Commentary: Apollo, Hannon Armstrong plan new issues; Transocean eyed; Redwood at par post-pricing
|
8/15/2017 | CV | Market Commentary: Morning Commentary: Redwood comes cheap; Great Ajax prices add-on; Apollo plans deal
|
8/14/2017 | CV | Market Commentary: Redwood Trust plans new six-year issue; Great Ajax announces add-on; secondary follows stocks
|
8/11/2017 | CV | Market Commentary: Resource Capital eyed after new issue prices; Heritage deal quiet; Sutherland notes list
|
8/11/2017 | CV | Market Commentary: Morning Commentary: Resource Capital eyed after new issue prices; Sutherland notes trade on NYSE
|
8/10/2017 | CV | Market Commentary: Resource Capital plans new issue; Heritage a no-show; BioMarin’s recent deal remains in play
|
8/10/2017 | CV | Market Commentary: Morning Commentary: Resource Capital plans new issue; BioMarin’s recent deal remains in play
|
8/9/2017 | CV | Market Commentary: Radius Health prices, dips below issue price; BioMarin busy; Priceline falters post-earnings
|
8/9/2017 | CV | Market Commentary: Morning Commentary: Radius Health prices, dips below issue price; BioMarin trading actively
|
8/8/2017 | CV | Market Commentary: BioMarin paper wanes in wake of new issue; Blackstone dips on add-on; Depomed tanks
|
8/8/2017 | CV | Market Commentary: Morning Commentary: BioMarin Pharmaceutical paper wanes in wake of new issue; Blackstone dips
|
8/7/2017 | CV | Market Commentary: New issue pipeline builds with deals from BioMarin, Blackstone, Radius; Tesla improves
|
8/7/2017 | CV | Market Commentary: Morning Commentary: Tesla convertibles trade actively, better on reports company to raise new debt
|
8/4/2017 | CV | Market Commentary: Electronics for Imaging bonds drop on accounting troubles; Teva convertibles falter
|
8/4/2017 | CV | Market Commentary: Morning Commentary: Electronics for Imaging bonds drop on accounting troubles; Sutherland prices
|
8/3/2017 | CV | Market Commentary: Tesla’s convertibles strengthen; Hologic cuts guidance, bonds weaken; Stericycle rises
|
8/3/2017 | CV | Market Commentary: Morning Commentary: Tesla’s convertible bonds gain after posting better-than-expected results
|
8/2/2017 | CV | Market Commentary: Innoviva new issue prices, trades actively; Illumina paper firms; Tesla up as results eyed
|
8/2/2017 | CV | Market Commentary: Morning Commentary: Innoviva prices, dominates early trading; Illumina paper firms post-earnings
|
8/1/2017 | CV | Market Commentary: Innoviva’s ‘old’ convertibles active ahead of new issue pricing; Intercept remains weak
|
8/1/2017 | CV | Market Commentary: Morning Commentary: Innoviva plans new eight-year convertible bonds; ‘old’ bonds decline
|
7/31/2017 | CV | Market Commentary: Intercept Pharmaceuticals topical on results, trial data; Hercules Capital unchanged
|
7/31/2017 | CV | Market Commentary: Morning Commentary: Hercules Capital trades flat ahead of earnings; Trinity Industries eyed
|
7/28/2017 | CV | Market Commentary: NuVasive drops outright but gains on swap; Intel in line after posting positive earnings
|
7/28/2017 | CV | Market Commentary: Morning Commentary: NuVasive sinks after results disappoint; Intel in line after positive earnings
|
7/27/2017 | CV | Market Commentary: U.S. convertibles mixed as earnings in focus; recently priced Teladoc adds dollar neutral
|
7/27/2017 | CV | Market Commentary: Morning Commentary: U.S. convertibles remain mixed; recently priced Teladoc adds dollar neutral
|
7/26/2017 | CV | Market Commentary: U.S. convertibles narrowly mixed; new Team lifts 1.5 points on swap; AMD jumps on earnings
|
7/26/2017 | CV | Market Commentary: Morning Commentary: New Team convertibles lift 1.5 points on swap; AMD jumps on positive earnings
|
7/25/2017 | CV | Market Commentary: Novavax loses ground; Pacira trial results disappoint; Medicines’ data positive, bonds flat
|
7/25/2017 | CV | Market Commentary: Morning Commentary: WebMD remains active but holds steady; new issue from Team on deck
|
7/24/2017 | CV | Market Commentary: WebMD convertibles jump on KKR purchase news; Arconic results beat as bonds wane; Novavax up
|
7/24/2017 | CV | Market Commentary: Morning Commentary: WebMD convertibles trade up in active dealings on KKR purchase news
|
7/21/2017 | CV | Market Commentary: New $1.5 billion mandatory deal from Crown Castle pushes past par; Becton paper rises
|
7/21/2017 | CV | Market Commentary: Morning Commentary: Convertibles investors eye new $1.5 billion mandatory deal from Crown Castle
|
7/20/2017 | CV | Market Commentary: Dermira active, steady; HubSpot trends up; Ensco drifts lower; Crown Castle deal eyed
|
7/20/2017 | CV | Market Commentary: Morning Commentary: Dermira convertibles active, steady; Crown Castle new issue on deck
|
7/19/2017 | CV | Market Commentary: Crown Castle adds mandatory deal to calendar; Becton paper firms; Twitter paper holds steady
|
7/19/2017 | CV | Market Commentary: Morning Commentary: Crown Castle adds mandatory deal to calendar; Twitter paper slightly weaker
|
7/18/2017 | CV | Market Commentary: Bellwether convertible issues in focus; DISH, Tesla bonds move with stock; Quidel gains
|
7/18/2017 | CV | Market Commentary: Morning Commentary: Bellwether convertible issues in focus; DISH paper declines with stock
|
7/17/2017 | CV | Market Commentary: Tesla bonds, equity active as Musk says stock price too high; Restoration Hardware slips
|
7/17/2017 | CV | Market Commentary: Morning Commentary: Tesla bonds up, equity drifts as Musk says price is too high
|
7/14/2017 | CV | Market Commentary: Liquidity muted as bank earnings in focus; Tesla, Micron active; Becton mandatories firm
|
7/14/2017 | CV | Market Commentary: Morning Commentary: Liquidity muted as bank earnings in focus; Tesla, Micron on the active side
|
7/13/2017 | CV | Market Commentary: Teva mandatories gain with stock on CEO chatter; Cobalt, Weatherford convertibles firm
|
7/13/2017 | CV | Market Commentary: Morning Commentary: Teva mandatories gain with stock on CEO chatter; Great Plains also firms
|
7/12/2017 | CV | Market Commentary: Convertible bond market liquidity muted; Twitter paper steady on CFO news; Tesla firms
|
7/12/2017 | CV | Market Commentary: Morning Commentary: Liquidity limited amid little news to move markets; Tesla firms with stock
|
7/11/2017 | CV | Market Commentary: Convertible market slightly weaker; Citrix Systems falls on CEO news; Vipshop bonds for sale
|
7/11/2017 | CV | Market Commentary: Morning Commentary: Convertible market slightly weaker to start session; Citrix falls on CEO news
|
7/10/2017 | CV | Market Commentary: Tesla convertibles firm in wake of Model 3 rollout; mandatories eyed; summer doldrums in play
|
7/10/2017 | CV | Market Commentary: Morning Commentary: Tesla convertibles seen better bid, though equity dips; summer doldrums in play
|
7/7/2017 | CV | Market Commentary: Tesla remains in focus as stock rebounds; Becton, Arconic preferreds also up with equity
|
7/7/2017 | CV | Market Commentary: Morning Commentary: Tesla remains in focus as stock rebounds; trading still constrained
|
7/6/2017 | CV | Market Commentary: Tesla convertibles, stock still in retreat on production, delivery concerns; market stays quiet
|
7/6/2017 | CV | Market Commentary: Morning Commentary: Tesla again eyed as stock remains in retreat; market still quiet
|
7/5/2017 | CV | Market Commentary: Post-holiday session mostly quiet; Tesla drops with shares on delivery concerns
|
7/5/2017 | CV | Market Commentary: Morning Commentary: Post-holiday session mostly quiet; Tesla in focus with shares down
|
7/3/2017 | CV | Market Commentary: Micron weakens again; Arconic in recovery mode; Acorda convertibles edge up with stock
|
7/3/2017 | CV | Market Commentary: Morning Commentary: Micron Technology weakens again; Acorda convertibles edge up with stock
|
6/30/2017 | CV | Market Commentary: Month-end, upcoming holiday weigh on convertibles; Arconic slides again; Micron declines
|
6/30/2017 | CV | Market Commentary: Morning Commentary: Month-end, upcoming holiday weigh on convertibles market; Arconic slides
|
6/29/2017 | CV | Market Commentary: EZCorp active, but little changed; Hurricane adds to calendar; liquidity low before holiday
|
6/29/2017 | CV | Market Commentary: Morning Commentary: EZCorp active but little moved; liquidity lightens ahead of holiday
|
6/28/2017 | CV | Market Commentary: Spectranetics flies higher on takeover news; Microchip busy, but steady; EZCorp on deck
|
6/28/2017 | CV | Market Commentary: Morning Commentary: Spectranetics being bought by Philips, convertibles fly higher; Microchip eyed
|
6/27/2017 | CV | Market Commentary: Convertible bond market follows equity space lower; Arconic slides; Weatherford weaker
|
6/27/2017 | CV | Market Commentary: Morning Commentary: Convertibles follow equities lower; ServiceNow, Tesla eyed
|
6/26/2017 | CV | Market Commentary: Yahoo/Altbaba convertibles rise, fall; Red Hat backs off; Starwood a ‘yield-to-maturity’ play
|
6/26/2017 | CV | Market Commentary: Morning Commentary: Tech names trade as overall liquidity remains limited
|
6/23/2017 | CV | Market Commentary: Synchronoss convertibles firm on buyout interest; Red Hat moves with stock; PROS paper eyed
|
6/23/2017 | CV | Market Commentary: Morning Commentary: Synchronoss convertibles firm on buyout interest; Red Hat moves with stock
|
6/22/2017 | CV | Market Commentary: STMicroelectronics prices two-tranche new issue; Teladoc moves above par; EnerNOC gains
|
6/22/2017 | CV | Market Commentary: Morning Commentary: STMicroelectronics plans two-tranche new issue; Teladoc moves above par
|
6/21/2017 | CV | Market Commentary: New Synaptics surges; Teladoc prices upsized deal; tech, healthcare up as energy tanks
|
6/21/2017 | CV | Market Commentary: Morning Commentary: New Synaptics surges; tech names in focus; Red Hat jumps with shares
|
6/20/2017 | CV | Market Commentary: Energy names sink with drop in oil prices; Tesla edges up; Synaptics, Teladoc notes on tap
|
6/20/2017 | CV | Market Commentary: Morning Commentary: Energy names sink outright with lower oil prices; Clovis Oncology quiet, gains
|
6/19/2017 | CV | Market Commentary: Clovis Oncology convertibles jump over 25 points on positive trial data; biotech follows
|
6/19/2017 | CV | Market Commentary: Morning Commentary: Clovis Oncology dominates trading, convertibles jump over 25 points on data
|
6/16/2017 | CV | Market Commentary: PROS Holdings prices issue at discount; Finisar convertibles firm despite weak results
|
6/16/2017 | CV | Market Commentary: Morning Commentary: PROS Holdings prices new issue at discount; Finisar firms despite results
|
6/15/2017 | CV | Market Commentary: Ctrip.com convertibles wane on exchange news; Tesla bonds give up recent gains, lock-up ends
|
6/15/2017 | CV | Market Commentary: Morning Commentary: Ctrip.com convertibles wane on exchange news; Tesla paper gives up gains
|
6/14/2017 | CV | Market Commentary: Tesla stock, convertible bonds post gains; energy issues in retreat as crude prices tumble
|
6/14/2017 | CV | Market Commentary: Morning Commentary: Tesla stock, convertible bonds continue to gain; trading thin as Fed eyed
|
6/13/2017 | CV | Market Commentary: Convertibles activity muted as Fed meets; Tesla gains on stock upgrade; Liberty Expedia firms
|
6/13/2017 | CV | Market Commentary: Morning Commentary: Convertible debt trading limited as Fed meets; Ctrip.com, Tesla gain momentum
|
6/12/2017 | CV | Market Commentary: New issue pipeline quiets down; Yahoo!, DISH convertibles give up some gains; Tesla steady
|
6/12/2017 | CV | Market Commentary: Morning Commentary: New issue pipeline quiets down; Yahoo!, DISH convertibles give up some gains
|
6/9/2017 | CV | Market Commentary: Invacare deal comes off of highs; Liberty Expedia’s new issue climbs; BlackRock steady
|
6/9/2017 | CV | Market Commentary: Morning Commentary: Invacare sells new issue; Liberty Expedia deal continues to climb; DISH firms
|
6/8/2017 | CV | Market Commentary: New convertible deals from BlackRock Capital, Liberty Expedia trade well; Yahoo! gains
|
6/8/2017 | CV | Market Commentary: Morning Commentary: New convertible deals from BlackRock Capital, Liberty Expedia trade well
|
6/7/2017 | CV | Market Commentary: New issue calendar builds with Liberty Expedia, Carrefour, Invacare and BlackRock on tap
|
6/7/2017 | CV | Market Commentary: Morning Commentary: Navistar convertibles in play post-earnings; Liberty, Carrefour add to calendar
|
6/6/2017 | CV | Market Commentary: Microchip higher as guidance raised; Acorda sees positive trial results; DISH gets a penalty
|
6/6/2017 | CV | Market Commentary: Morning Commentary: Newmont Mining busy but steady ahead of maturity; Microchip edges higher
|
6/5/2017 | CV | Market Commentary: Convertibles activity slows; Herbalife falters as guidance altered; Restoration Hardware eyed
|
6/5/2017 | CV | Market Commentary: Morning Commentary: Convertible debt trading still weak; Herbalife falters as guidance altered
|
6/2/2017 | CV | Market Commentary: Convertibles investors ‘shuffle paper around’ on modest stock moves; ServiceNow, PRA trade up
|
6/2/2017 | CV | Market Commentary: Morning Commentary: Vipshop convertibles trade up with stock; Rayonier mandatories lose ground
|
6/1/2017 | CV | Market Commentary: Palo Alto convertibles jump after posting better-than-expected results; Tesla paper ends firm
|
6/1/2017 | CV | Market Commentary: Morning Commentary: Palo Alto Networks’ convertibles jump on better-than-expected results
|
5/31/2017 | CV | Market Commentary: NXP convertibles gain as market mulls Qualcomm merger; health care names slip; volume thin
|
5/31/2017 | CV | Market Commentary: Morning Commentary: Trading thins as holidays lure players out of the office; NXP convertibles firm
|
5/30/2017 | CV | Market Commentary: Ensco’s 3% exchangeables falter as merger with Atwood announced; Becton mandatories better
|
5/30/2017 | CV | Market Commentary: Morning Commentary: Ensco’s 3% exchangeables falter as merger with Atwood announced
|
5/26/2017 | CV | Market Commentary: Demand for mandatories remains strong; DISH continues to trade; PRA bonds edge upward
|
5/26/2017 | CV | Market Commentary: Morning Commentary: Mandatories in focus as convertibles market quiets into holiday weekend
|
5/25/2017 | CV | Market Commentary: LendingTree’s new 0.625% convertibles do well on debut; ServiceNow a dud; PRA Group edges up
|
5/25/2017 | CV | Market Commentary: Morning Commentary: LendingTree’s new 0.625% convertibles do well on debut; ServiceNow a dud
|
5/24/2017 | CV | Market Commentary: New ServiceNow slips below par; old ServiceNow steady; Dycom expands as shares tank
|
5/24/2017 | CV | Market Commentary: Morning Commentary: New ServiceNow convertibles slip on debut; old ServiceNow bond steady
|
5/23/2017 | CV | Market Commentary: PRA Group’s new convertible issue takes focus; ServiceNow’s 0% notes slip ahead of new issue
|
5/23/2017 | CV | Market Commentary: Morning Commentary: PRA Group moves over par post-pricing; ServiceNow deal eyed as older issue dips
|
5/22/2017 | CV | Market Commentary: Deals from PRA, Capitala, ServiceNow added to pipeline; DISH little moved on Amazon news
|
5/22/2017 | CV | Market Commentary: Morning Commentary: PRA Group adds new deal to calendar; market hits snooze; Capitala also on tap
|
5/19/2017 | CV | Market Commentary: Recent convertible bond issues in focus; Atlas Air tops trading activity; Stanley units list
|
5/19/2017 | CV | Market Commentary: Morning Commentary: New convertible bond issues in focus; Atlas Air tops trading activity
|
5/18/2017 | CV | Market Commentary: Sources have mixed feelings about new Atlas deal; RealPage outperforms; Becton lists on NYSE
|
5/18/2017 | CV | Market Commentary: Morning Commentary: Atlas Air struggles post-pricing; RealPage performs well; Becton lists on NYSE
|
5/17/2017 | CV | Market Commentary: DISH convertibles rise on Amazon deal chatter; RealPage, Atlas Air deals eyed
|
5/17/2017 | CV | Market Commentary: Morning Commentary: DISH convertibles rise on Amazon chatter; RealPage, Atlas deals on deck
|
5/16/2017 | CV | Market Commentary: Atlas Air, RealPage add deals to calendar; Yahoo! firms on stock buyback; SINA stronger
|
5/16/2017 | CV | Market Commentary: Morning Commentary: Yahoo! convertibles active, firm on stock buyback; Spirit Realty eyed
|
5/15/2017 | CV | Market Commentary: Convertibles mostly quiet, but mandatories better bid; Black & Decker gains on swap
|
5/15/2017 | CV | Market Commentary: Morning Commentary: Convertibles mostly quiet; mandatories better bid; Becton Dickinson edges up
|
5/12/2017 | CV | Market Commentary: Stanley Black & Decker notches strong debut; Dermira deal touted; Becton Dickinson does well
|
5/12/2017 | CV | Market Commentary: Morning Commentary: New Stanley trades up out of the gate; Becton Dickinson remains strong
|
5/11/2017 | CV | Market Commentary: Primary sees deal flow of $3.15 billion; Becton prices; Dermira rises; Black & Decker on tap
|
5/11/2017 | CV | Market Commentary: Morning Commentary: Primary sees deal flow of $3.15 billion; Becton prices; Black & Decker on tap
|
5/10/2017 | CV | Market Commentary: Depomed convertible notes recover from day’s lows; Vitamin Shoppe loses ground
|
5/10/2017 | CV | Market Commentary: Morning Commentary: Depomed convertibles weaken on wider loss; Dermira, Becton deals on deck
|
5/9/2017 | CV | Market Commentary: New deals from DexCom, Kaman active post-pricing; Dermira adds to calendar; Becton on tap
|
5/9/2017 | CV | Market Commentary: Morning Commentary: New issues from DexCom, Kaman climb above par in active trading
|
5/8/2017 | CV | Market Commentary: DexCom, Kaman, Becton Dickinson enter market; Horizon falters as guidance lowered; Cobalt up
|
5/8/2017 | CV | Market Commentary: Morning Commentary: DexCom, Kaman, Becton Dickinson plan to tap market; Horizon falters
|
5/5/2017 | CV | Market Commentary: AMAG deal comes upsized, cheap; HubSpot ‘aggressively priced’; Herbalife edges higher
|
5/5/2017 | CV | Market Commentary: Morning Commentary: AMAG Pharmaceuticals deal comes upsized, cheap; HubSpot prices rich
|
5/4/2017 | CV | Market Commentary: Spirit Realty convertibles tumble on earnings miss; Lumentum trades higher on 3D hopes
|
5/4/2017 | CV | Market Commentary: Morning Commentary: Spirit Realty convertibles tumble on earnings miss; Lumentum trades higher
|
5/3/2017 | CV | Market Commentary: AMAG, HubSpot add deals to calendar; Tesla drops ahead of earnings; Akamai trades off
|
5/3/2017 | CV | Market Commentary: Morning Commentary: Akamai results beat, but weak guidance weighs on convertibles; FireEye firms
|
5/2/2017 | CV | Market Commentary: AMD convertibles retreat on profit margin worries; Rayonier dips on miss; Blackstone flat
|
5/2/2017 | CV | Market Commentary: Morning Commentary: Blackstone Mortgage hovers around discounted issue price; AMD debt trades lower
|
5/1/2017 | CV | Market Commentary: Blackstone Mortgage in market; recent deals in play; BroadSoft hit post-earnings
|
5/1/2017 | CV | Market Commentary: Morning Commentary: Synchronoss active; Neurocrine holds in; Blackstone Mortgage in market
|
4/28/2017 | CV | Market Commentary: Flexion’s new issue expands; DISH deemed ‘better to buy’ but unchanged; Weatherford adds
|
4/28/2017 | CV | Market Commentary: Morning Commentary: Flexion’s new issue expands; DISH deemed ‘better to buy’ but unchanged
|
4/27/2017 | CV | Market Commentary: New convertibles from Flexion, Neurocrine jump over par post-pricing; Synchronoss suffers
|
4/27/2017 | CV | Market Commentary: Morning Commentary: New deals from Flexion, Neurocrine jump over par post-pricing
|
4/26/2017 | CV | Market Commentary: Twitter tops estimates, convertibles flat; Anthem firms on earnings; new deals on tap
|
4/26/2017 | CV | Market Commentary: Morning Commentary: Twitter beats estimates but little changed; Flexion, Neurocrine deals in focus
|
4/25/2017 | CV | Market Commentary: Flexion, Neurocrine add deals to calendar; Tesla, InterDigital little moved ahead of earnings
|
4/25/2017 | CV | Market Commentary: Morning Commentary: Tesla, InterDigital little changed as market preps for earnings; Iconix steady
|
4/24/2017 | CV | Market Commentary: Another round of earnings on deck; Illumina, Anthem up ahead of results; FelCor rises
|
4/24/2017 | CV | Market Commentary: Morning Commentary: Illumina convertibles trade ahead of earnings; FelCor rises on merger news
|
4/21/2017 | CV | Market Commentary: Earnings, French election weigh on liquidity; Great Plains retreats; Anthem weakens
|
4/21/2017 | CV | Market Commentary: Morning Commentary: Earnings, French election weigh on liquidity; Great Plains gives up some gains
|
4/20/2017 | CV | Market Commentary: New deal from Great Ajax deemed a dud; Tesla flat despite recall news; Great Plains gains
|
4/20/2017 | CV | Market Commentary: Morning Commentary: New deal from Great Ajax deemed a dud; Arconic paper rebounding from lows
|
4/19/2017 | CV | Market Commentary: DISH remains topical in convertibles market; Finisar paper slips on China slowdown worries
|
4/19/2017 | CV | Market Commentary: Morning Commentary: DISH Network topical in convertibles market; Finisar paper slips
|
4/18/2017 | CV | Market Commentary: GNC convertibles rise as earnings beat estimates; Arconic paper declines amid CEO departure
|
4/18/2017 | CV | Market Commentary: Morning Commentary: Convertible bond market trading remains low; Newmont busy but unchanged
|
4/17/2017 | CV | Market Commentary: Holidays pressure convertible bond market activity; Forestar slightly better on merger news
|
4/17/2017 | CV | Market Commentary: Morning Commentary: Holidays continue to pressure convertible bond market activity; Forestar stalls
|
4/13/2017 | CV | Market Commentary: Holiday weighs on convertibles activity; Vipshop, Liberty Media up outright; Scorpio steady
|
4/13/2017 | CV | Market Commentary: Morning Commentary: Holiday weighs on convertible market activity; Inphi mixed; Ashford up
|
4/12/2017 | CV | Market Commentary: Convertible bond go-gos like Priceline, Tesla trade; Chesapeake up, but down from day’s highs
|
4/12/2017 | CV | Market Commentary: Morning Commentary: Convertible bond go-gos like Priceline, Tesla trade; Chesapeake gains ground
|
4/11/2017 | CV | Market Commentary: Convertible bond trading muted amid geopolitical issues; Priceline active; GoPro gains ground
|
4/11/2017 | CV | Market Commentary: Morning Commentary: Convertible bond trading muted amid geopolitical issues; Priceline steady
|
4/10/2017 | CV | Market Commentary: Tesla aims for biggest U.S. automaker, convertibles rise; DISH improves; Cobalt firm
|
4/10/2017 | CV | Market Commentary: Morning Commentary: Tesla takes over as biggest automaker, convertibles rise; Cobalt firm
|
4/7/2017 | CV | Market Commentary: GoPro prices upsized convertibles; Prospect Capital paper active; Cobalt firm in secondary
|
4/7/2017 | CV | Market Commentary: Morning Commentary: GoPro prices upsized issue in line with talk; Prospect Capital active
|
4/6/2017 | CV | Market Commentary: Prospect Capital prices new deal; older issues active; GoPro next up; Cobalt trades higher
|
4/6/2017 | CV | Market Commentary: Morning Commentary: Prospect Capital prices new deal; older issues active; GoPro next up
|
4/5/2017 | CV | Market Commentary: Primary calendar builds; Greenbrier pops on earnings beat, Mitsubishi deal; Teradyne ticks up
|
4/5/2017 | CV | Market Commentary: Morning Commentary: Greenbrier convertibles pop on earnings beat; Tesla dips as rival eyes funding
|
4/4/2017 | CV | Market Commentary: Acorda convertibles under pressure; Depomed edges up on debt payment; Gogo goes up
|
4/4/2017 | CV | Market Commentary: Morning Commentary: Acorda Therapeutics convertibles under pressure; Depomed edges up on payment
|
4/3/2017 | CV | Market Commentary: Convertible bond trading limited; Tesla paper rises on shipments; Acorda patents nixed
|
4/3/2017 | CV | Market Commentary: Morning Commentary; Convertible bond trading limited as quarter kicks off; Tesla rises on shipments
|
3/31/2017 | CV | Market Commentary: Convertibles trading muted to end quarter; Carbonite firm; Cobalt paper gains; DISH up
|
3/31/2017 | CV | Market Commentary: Morning Commentary: Trading muted in quarter-end session; Carbonite remains firm; DISH Network up
|
3/30/2017 | CV | Market Commentary: Carbonite new deal prices, trades above par; WebMD convertible bonds in focus on sale reports
|
3/30/2017 | CV | Market Commentary: Morning Commentary: Carbonite prices new deal, trades above par; WebMD in focus on sale reports
|
3/29/2017 | CV | Market Commentary: Energy convertibles gain with oil; Restoration Hardware firms; WebMD up on sale news
|
3/29/2017 | CV | Market Commentary: Morning Commentary: Restoration Hardware firms post-earnings; energy convertibles gain with oil
|
3/28/2017 | CV | Market Commentary: Tesla convertibles improve on Tencent investment; Red Hat firms; Carbonite deal on tap
|
3/28/2017 | CV | Market Commentary: Morning Commentary: Tesla convertible bonds improve on Tencent investment; Square backs down
|
3/27/2017 | CV | Market Commentary: Convertibles wane; Red Hat slips ahead of earnings; Gogo goes down; Alexandria paper pops
|
3/27/2017 | CV | Market Commentary: Morning Commentary: Convertible bonds wane; Red Hat eyed ahead of earnings; Gogo goes down
|
3/24/2017 | CV | Market Commentary: New Starwood slips on debut; older Starwood adds; Micron lower on swap; newest Tesla lower
|
3/24/2017 | CV | Market Commentary: Morning Commentary: New Starwood slips on debut; older Starwood adds; Micron lower on swap
|
3/23/2017 | CV | Market Commentary: Tesla’s new bond improves; Starwood Properties launches deal; FireEye adds outright
|
3/23/2017 | CV | Market Commentary: Morning Commentary: Convertibles quiet as health care vote looms; FireEye adds outright
|
3/22/2017 | CV | Market Commentary: Tesla’s new bond improves; convertible market pauses after Tuesday’s stock market sell-off
|
3/22/2017 | CV | Market Commentary: Morning Commentary: Convertibles market pauses following Tuesday’s stock market sell-off
|
3/21/2017 | CV | Market Commentary: Tesla’s convertibles weaken as stock markets broadly sell off; oil-services names lower
|
3/21/2017 | CV | Market Commentary: Morning Commentary: Jazz Pharmaceuticals, Vipshop trading firm to better despite stock markets’ sag
|
3/20/2017 | CV | Market Commentary: Tesla’s new issue remains in focus; Viavi ticks up; Medicines rebounds from Friday lows
|
3/20/2017 | CV | Market Commentary: Morning Commentary: Tesla’s new issue remains in focus; Viavi ticks up; Medicines rebounds
|
3/17/2017 | CV | Market Commentary: Tesla’s new deal in focus, comes ‘under pressure’; ON’s recent deal does ‘OK’; Medicines falters
|
3/17/2017 | CV | Market Commentary: Morning Commentary: Convertibles market focuses on new Tesla deal; ON firms; Medicines falters
|
3/16/2017 | CV | Market Commentary: Tesla dominates trading after new deal announced; ON new issue steady; Walter remains in retreat
|
3/16/2017 | CV | Market Commentary: Morning Commentary: Tesla dominates trading after new deal announced; ON’s new issue steady
|
3/15/2017 | CV | Market Commentary: ON Semiconductor improves; Nuance stays below par; Tesla to tap the market; Walter declines
|
3/15/2017 | CV | Market Commentary: Morning Commentary: ON Semiconductor does well post-pricing; Nuance stays below par
|
3/14/2017 | CV | Market Commentary: Convertibles wane with market; Nuance goes sub-par post-pricing; Citrix active on sale talk
|
3/14/2017 | CV | Market Commentary: Morning Commentary: Convertibles wane with market; Nuance goes sub-par post-pricing; Citrix slips
|
3/13/2017 | CV | Market Commentary: Nuance, ON enter market; Dish’s new deal does well post-pricing; Intel slips on Mobileye buy
|
3/13/2017 | CV | Market Commentary: Morning Commentary: Dish’s deal does well; Nuance enters market; Intel slips on Mobileye buy
|
3/10/2017 | CV | Market Commentary: DISH offers new convertibles, older notes retreat; Finisar convertibles drop on earnings
|
3/10/2017 | CV | Market Commentary: Morning Commentary: DISH to tap market, existing paper retreats; Finisar sees earnings miss
|
3/9/2017 | CV | Market Commentary: Pacira retreats from post-pricing highs; Nabors trends lower; oil names remain under pressure
|
3/9/2017 | CV | Market Commentary: Morning Commentary: Pacira comes off highs; Nabors trends lower, in line with broader market
|
3/8/2017 | CV | Market Commentary: Pacira deal prices rich, pops above par; Impax improves on strategic review; Chesapeake drops
|
3/8/2017 | CV | Market Commentary: Morning Commentary: Pacira deal prices rich, pops above par; Impax rises on strategic review news
|
3/7/2017 | CV | Market Commentary: Weatherford rises as new CEO tapped; DISH pops on S&P 500 add; Square comes in; Pacira on tap
|
3/7/2017 | CV | Market Commentary: Morning Commentary: Weatherford rises as new CEO tapped; DISH pops on S&P 500 add; Pacira on deck
|
3/6/2017 | CV | Market Commentary: Convertibles flat to lower as broader markets sink; Lumentum slips; Pacira launches deal
|
3/6/2017 | CV | Market Commentary: Morning Commentary: Convertibles heavy as broader markets sink; Lumentum slips after strong debut
|
3/3/2017 | CV | Market Commentary: Lumentum prices rich, comes upsized; Ashford falls on add-on; Square active; AmTrust higher
|
3/3/2017 | CV | Market Commentary: Morning Commentary: Lumentum prices rich, comes upsized; Ashford falls on add-on; Square active
|
3/2/2017 | CV | Market Commentary: Lumentum deal added to convertibles calendar; Viavi fades; PTC drops on clinical trial news
|
3/2/2017 | CV | Market Commentary: Morning Commentary: New Lumentum deal added to convertibles calendar; Square, Silicon do well
|
3/1/2017 | CV | Market Commentary: Square deal comes upsized, jumps over par; Silicon prices; Viavi still busy; Ashford on tap
|
3/1/2017 | CV | Market Commentary: Morning Commentary: Square deal comes upsized, jumps over par; Silicon prices; Viavi still busy
|
2/28/2017 | CV | Market Commentary: Viavi’s new deal does well on the break; Encore issue lackluster; HCI upsized; calendar eyed
|
2/27/2017 | CV | Market Commentary: New deals from Encore, Viavi, Silicon Labs and Square on tap; Tesla stock downgraded
|
2/27/2017 | CV | Market Commentary: Morning Commentary: Encore Capital, Viavi plan new issues; Tesla stock downgraded, bonds lower
|
2/24/2017 | CV | Market Commentary: Microchip turns around in tandem with underlying shares as broader market reverses course
|
2/24/2017 | CV | Market Commentary: Morning Commentary: Microchip convertible issues trading little changed as market tapers off
|
2/23/2017 | CV | Market Commentary: Busy convertible market firms slightly; Vipshop flat; Ctrip mixed to better after earnings
|
2/23/2017 | CV | Market Commentary: Morning Commentary: Tesla convertibles add on swap after mixed earnings; Ctrip trading on earnings
|
2/22/2017 | CV | Market Commentary: Parker Drilling’s new preferreds fizzle; fresh earnings drive movement in DISH, Tesla
|
2/22/2017 | CV | Market Commentary: Morning Commentary: Parker prices but doesn’t impress; Microchip active; Vipshop little changed
|
2/21/2017 | CV | Market Commentary: Holiday weighs on convertible bond volume; primary calendar builds; Vipshop firms
|
2/21/2017 | CV | Market Commentary: Morning Commentary: Holiday weighs on convertible bond volume; Vipshop firms post-earnings
|
2/17/2017 | CV | Market Commentary: Finisar pressured by module troubles; OSI deal steady but subdued; Hornbeck remains weak
|
2/17/2017 | CV | Market Commentary: Morning Commentary: Finisar under pressure; OSI steady but subdued; Hornbeck remains weak
|
2/16/2017 | CV | Market Commentary: OSI comes ‘aggressive’; secondary market seen cheaper; Molina expands on dollar-neutral basis
|
2/16/2017 | CV | Market Commentary: Morning Commentary: OSI’s new deal comes ‘aggressive’; Golar, Microchip notes hold around par
|
2/15/2017 | CV | Market Commentary: Tesla convertibles firm as market bets on earnings; Microchip, Golar in play; OSI on tap
|
2/15/2017 | CV | Market Commentary: Morning Commentary: Tesla convertibles, stock up as market bets on earnings; OSI Systems on tap
|
2/14/2017 | CV | Market Commentary: Golar LNG’s new issue trades over par post-pricing; OSI Systems in the market; Microchip eyed
|
2/14/2017 | CV | Market Commentary: Morning Commentary: Golar LNG’s new issue trades over par post-pricing; Microchip remains in play
|
2/13/2017 | CV | Market Commentary: Microchip’s new 1.625% issue gains ground; Priceline busy; Golar offers five-year notes
|
2/13/2017 | CV | Market Commentary: Morning Commentary: Microchip’s new 1.625% convertibles gain ground; Priceline active, weaker
|
2/10/2017 | CV | Market Commentary: Microchip’s new deals trade ‘around par’ post-pricing; Acorda gains; Immunomedics rises
|
2/10/2017 | CV | Market Commentary: Morning Commentary: Microchip’s new deals trade ‘around par’ post-pricing; Acorda gains momentum
|
2/9/2017 | CV | Market Commentary: Microchip busy, weaker ahead of new issue; Twitter declines post-earnings; Medidata improves
|
2/9/2017 | CV | Market Commentary: Morning Commentary: Microchip busy, weaker ahead of new issue; Twitter releases earnings
|
2/8/2017 | CV | Market Commentary: Microchip convertibles pop post-earnings, plans to tap market; Zillow notes decline
|
2/8/2017 | CV | Market Commentary: Morning Commentary: Microchip convertibles pop post-earnings; Zillow in decline; Nabors active
|
2/7/2017 | CV | Market Commentary: Convertibles little changed in light volume; FXCM crumbles; Zillow quiet ahead of earnings
|
2/7/2017 | CV | Market Commentary: Morning Commentary: Convertibles little changed in light volume; Zillow see positive tone
|
2/6/2017 | CV | Market Commentary: Convertibles see positive tone; Greenbrier adds 3 points since issue; Medicines extends gains
|
2/6/2017 | CV | Market Commentary: Morning Commentary: Convertible market quiet amid positive tone; Greenbrier up 3 points since issue
|
2/3/2017 | CV | Market Commentary: Convertible bond market continues to eye earnings; FireEye paper weakens; Weatherford firms
|
2/3/2017 | CV | Market Commentary: Morning Commentary: Convertible bond market continues to eye earnings; FireEye paper weakens
|
2/2/2017 | CV | Market Commentary: FireEye beats expectations; Shutterfly convertibles falter on earnings; CSG Systems weakens
|
2/2/2017 | CV | Market Commentary: Morning Commentary: Greenbrier holds steady; market readies for FireEye earnings; Shutterfly dips
|
2/1/2017 | CV | Market Commentary: Greenbrier prices rich, comes upsized; AMD pops post-earnings; Dish Network trades higher
|
2/1/2017 | CV | Market Commentary: Morning Commentary: Greenbrier convertibles price rich, come upsized; AMD pops post-earnings
|
1/31/2017 | CV | Market Commentary: Greenbrier deal set to price; Teva convertibles in decline as patents nixed; Rayonier lower
|
1/31/2017 | CV | Market Commentary: Morning Commentary: Greenbrier deal set to price; Teva convertibles in decline as patents nixed
|
1/30/2017 | CV | Market Commentary: Convertibles weaken with stocks; Ares Capital’s new issue trades sub-par; Greenbrier on tap
|
1/30/2017 | CV | Market Commentary: Morning Commentary: Convertibles weaken with stocks; Ares Capital’s new issue trades below par
|
1/27/2017 | CV | Market Commentary: New deal from Horizon Global pops; Virtus holds up post-pricing; TPG Specialty at par
|
1/27/2017 | CV | Market Commentary: Morning Commentary: New deal from Horizon Global pops; Virtus holds up post-pricing; TPG at par
|
1/26/2017 | CV | Market Commentary: ServiceNow, Teradyne gain post-earnings; DISH slides on Verizon-Charter chatter; supply eyed
|
1/26/2017 | CV | Market Commentary: Morning Commentary: ServiceNow, Teradyne gain post-earnings; TPG adds to new issue pipeline
|
1/25/2017 | CV | Market Commentary: Ares Capital’s new deal straddles par; Liberty firms; Horizon Global, Virtus deals coming up
|
1/25/2017 | CV | Market Commentary: Morning Commentary: Ares Capital’s new convertibles lose momentum; Horizon’s upcoming deal eyed
|
1/24/2017 | CV | Market Commentary: Ares Capital deal trades over par post-pricing; Horizon Global on tap; Yahoo! active
|
1/24/2017 | CV | Market Commentary: Morning Commentary: Ares Capital deal tops par post-pricing; Yahoo! active, better on results
|
1/23/2017 | CV | Market Commentary: Convertibles muted as week kicks off; Ares Capital bringing five-year paper; Cascadian on tap
|
1/23/2017 | CV | Market Commentary: Morning Commentary: Convertibles muted as week kicks off; Ares Capital bringing five-year paper
|
1/20/2017 | CV | Market Commentary: Liberty Media, Hercules trade over par post-pricing on ‘good volume’; Herbalife active
|
1/20/2017 | CV | Market Commentary: Morning Commentary: Liberty Media, Hercules over par post-pricing; market sees ‘good volume’
|
1/19/2017 | CV | Market Commentary: Market awaits new deals from Hercules, Liberty; Nabors in focus; Finisar convertibles firm
|
1/19/2017 | CV | Market Commentary: Morning Commentary: Market awaits new deals from Hercules, Liberty; Nabors remains in focus
|
1/18/2017 | CV | Market Commentary: Convertible bond market muted; New York Mortgage prices; Hercules Capital on tap
|
1/18/2017 | CV | Market Commentary: Morning Commentary: Convertibles subdued as market eyes new presidency; New York Mortgage prices
|
1/17/2017 | CV | Market Commentary: Convertibles little changed; AMD expands slightly; New York Mortgage to price five-year bond
|
1/17/2017 | CV | Market Commentary: Morning Commentary: AMD expands slightly; New York Mortgage to price five-year bond at discount
|
1/13/2017 | CV | Market Commentary: Two Harbors sells upsized deal, trades just over par; Pandora paper rises; SL Green at parity
|
1/13/2017 | CV | Market Commentary: Morning Commentary: Two Harbors brings upsized deal, trades just over par; SL Green paper active
|
1/12/2017 | CV | Market Commentary: New deals from Veeco Instruments, NICE Systems trade above par; Two Harbors added to pipeline
|
1/12/2017 | CV | Market Commentary: Morning Commentary: New deals from Veeco Instruments, NICE Systems trade above par
|
1/11/2017 | CV | Market Commentary: Convertible bond market players eye primary; MagnaChip comes upsized; Nabors trades actively
|
1/11/2017 | CV | Market Commentary: Morning Commentary: Convertible bond market players eye primary; MagnaChip comes upsized
|
1/10/2017 | CV | Market Commentary: Primary market sees new deal from Nabors Industries; calendar builds; Illumina pops
|
1/10/2017 | CV | Market Commentary: Morning Commentary: Primary market gets some action with new deal from Nabors Industries
|
1/9/2017 | CV | Market Commentary: Ariad Pharmaceuticals jumps on Takeda takeover news; AMAG paper suffers; Nabors deal on tap
|
1/9/2017 | CV | Market Commentary: Morning Commentary: Ariad Pharmaceuticals jumps on Takeda takeover news; Dow Jones in focus
|
1/6/2017 | CV | Market Commentary: Biotech sector firm, led by Medicines, Ionis; Pandora convertibles in decline; Colony dips
|
1/6/2017 | CV | Market Commentary: Morning Commentary: Biotech sector firm, led by Medicines, Ionis; Pandora convertibles in decline
|
1/5/2017 | CV | Market Commentary: Colony Starwood’s new deal trades above par; Michelin taps the market; Clovis on the rise
|
1/5/2017 | CV | Market Commentary: Morning Commentary: Colony Starwood’s new deal trades above par in active dealings; Michelin on tap
|
1/4/2017 | CV | Market Commentary: Convertibles mixed as trading picks up; Tesla edges up in long-only trade; Illumina slips
|
1/3/2017 | CV | Market Commentary: Convertibles muted, but volatility could be ahead; Colony Starwood launches year’s first deal
|
1/3/2017 | CV | Market Commentary: Morning Commentary: Convertible bonds muted but volatility could be ahead; Delek buying out Alon
|